San Diego, CA, United States of America

Dwayne Stupack


Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Dwayne Stupack: Innovator in Melanoma Treatment

Introduction

Dwayne Stupack is a notable inventor based in San Diego, California. He has made significant contributions to the field of medical science, particularly in the treatment of melanoma. His innovative work focuses on developing methods to treat and ameliorate melanoma and kill melanoma cells.

Latest Patents

Stupack holds a patent for "Methods for treating or ameliorating a melanoma and killing melanoma cells." This invention provides novel compositions, including lipopeptides and their analogs, such as somocystinamide A and its variants. The patent outlines pharmaceutical compositions, liposomes, and nanoparticles that incorporate these lipopeptides. These compositions are designed to induce apoptosis in various cell types, including normal, dysfunctional, and cancerous cells. Additionally, the invention addresses the treatment of tumor-associated blood vessels, including endothelial and capillary cell growth.

Career Highlights

Dwayne Stupack is affiliated with the University of California, where he continues to advance his research and innovation in the medical field. His work has the potential to significantly impact the treatment of melanoma and improve patient outcomes.

Collaborations

Stupack has collaborated with esteemed colleagues, including William H. Gerwick and Wolfgang J. Wrasidlo. These partnerships have contributed to the advancement of his research and the development of effective treatment methods.

Conclusion

Dwayne Stupack's innovative contributions to melanoma treatment exemplify the importance of research and development in the medical field. His patented methods and compositions hold promise for improving the lives of those affected by this challenging disease.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…